The Health Advocates

Public health threats often seem unrelated until we examine the systems that connect them. In this episode of The Health Advocates, Steven Newmark discusses the record-breaking rise in U.S. measles cases, recent foodborne illness outbreaks, changing COVID-19 activity, and the health risks associated with wildfire smoke.

Steven explains what these developments mean for patients, caregivers, and people living with chronic illness, in...

The COVID-19 public health emergency may be over, but for millions of Americans with weakened immune systems, the virus remains a serious concern.

In this episode of The Health Advocates, Steven Newmark breaks down a recent announcement from the U.S. Department of Health and Human Services to phase out COVID-19 Emergency Use Authorizations (EUAs) and explains why the decision matters for people who are immunocompromised. The transi...

As the United States celebrates its 250th birthday, The Health Advocates takes a look at a different kind of American history, the story of our nation's fight against disease and the policies that have shaped the health of millions.

Host Steven Newmark traces 250 years of U.S. health policy, beginning with George Washington's bold decision to inoculate the Continental Army against smallpox and continuing through the development of ...

What happens at one of the world's largest rheumatology conferences, and why should patients care?

In this special episode of The Health Advocates, Steven Newmark is joined by Dr. Shilpa Venkatachalam, Director of Patient-Centered Research at the Global Healthy Living Foundation (GHLF), to discuss the biggest takeaways from EULAR 2026, the annual congress of the European Alliance of Associations for Rheumatology.

The conversation e...

What actually happens at a major international medical conference — and why should patients care?

In this episode of The Health Advocates, Steven Newmark reports from EULAR 2026 in London, one of the world’s largest rheumatology conferences, to explain how meetings like this help shape the future of patient care. The episode explores why conferences matter not just for doctors and researchers, but for patients and advoc...

Something bigger than a single vaccine debate is unfolding inside America’s public health system.

In this episode of The Health Advocates, Steven Newmark explores the growing tension surrounding vaccine policy, scientific transparency, and public trust. From the FDA’s decision not to review a new mRNA flu vaccine application to reports of delayed vaccine safety studies and shifting federal recommendations, the episode c...

The federal budget may feel distant, but its impact on healthcare is anything but. In this episode of The Health Advocates, Steven Newmark breaks down the Trump administration’s newly proposed budget, which includes significant cuts to the Department of Health and Human Services, reductions in research funding, and a major restructuring of federal public health programs.

But this conversation goes beyond what’s proposed...

A federal court has halted sweeping changes to U.S. vaccine policy, raising fundamental questions about who shapes public health decisions and how those decisions are made. In this episode, we break down the ruling, the role of the CDC’s vaccine advisory committee, and why the court found the administration’s actions unlawful. We also explore what this means for patients, providers, and the future of evidence-based poli...

For people living with osteoarthritis, news about potential new treatments often comes with more questions than answers. In this episode of The Health Advocates, we slow things down to explain what it really means when a company submits a New Drug Application, or NDA, to the U.S. Food and Drug Administration.

Steven Newmark is joined by Erich Horsley and Dr. Yusuf Yazici from Biosplice Therapeutics to walk through this important re...

This week on The Health Advocates, we unpack a series of developments that signal a pivotal moment in U.S. health policy. The FDA has refused to review Moderna’s new mRNA-based flu vaccine, raising questions about regulatory standards and the future of vaccine innovation. At the same time, the Trump administration has launched TrumpRx, a new prescription drug discount platform that promises savings but faces scrutiny over its...

Congress has passed, and President Trump has signed, a major government funding bill that includes a wide range of health care policies, from telehealth extensions and hospital-at-home programs to long-sought reforms targeting pharmacy benefit managers. But alongside those wins, the legislation also raises serious questions about the future direction of federal health policy.

In this episode of The Health Advocates, Steven New...

In this episode of The Health Advocates, Steven Newmark sits down with Dr. Cynthia Overton to explore what person‑centered care truly looks like, through the eyes of someone who has lived it.

At age 26, Cynthia experienced a sudden spinal cord injury that left her temporarily paralyzed—an event that fundamentally reshaped her understanding of health care. Today, she draws on both lived experience and evidence‑based frameworks...

In this episode of The Health Advocates, Steven Newmark breaks down a surprising moment of bipartisan agreement in Congress: a new Health and Human Services funding bill that includes meaningful wins for patients and public health.

From protecting CDC and NIH funding to extending telehealth flexibilities and hospital-at-home p...

In this episode of The Health Advocates, Steven Newmark speaks with Ohio State Representative Michele Grim, the only public health professional currently serving in the Ohio legislature. Rep. Grim shares how her background in public health advocacy led her to politics, where she now champions legislation to expand access to care, fight misinformation, and protect vulnerable populations.

Together, they dive into the challenges of he...

In this episode of The Health Advocates, we break down one of the most pivotal and controversial ACIP meetings in recent history. The CDC’s vaccine advisory committee voted to roll back the universal hepatitis B birth dose, a policy that has protected newborns from chronic liver disease for more than three decades. We explain what ACIP decided, why the changes were not based on new scientific evidence, and how misinformation ...

In this special year-end episode of The Health Advocates, host Steven Newmark takes a step back to review several of the most significant public health developments of 2025.

The episode covers major leadership changes at the U.S. Department of Health and Human Services, key meetings and votes of the Advisory Committee on Immunization Practices (ACIP), ongoing challenges related to vaccine access and uptake, and continued deb...

In this episode of The Health Advocates, we break down one of the most pivotal and controversial ACIP meetings in recent history. The CDC’s vaccine advisory committee voted to roll back the universal hepatitis B birth dose — a policy that has protected newborns from chronic liver disease for more than three decades. We explain what ACIP decided, why the changes were not based on new scientific evidence, and how misinfor...

How can lawmakers rebuild public trust in health, and make prevention a shared priority?

In this episode of The Health Advocates, Steven Newmark speaks with Texas State Representative Nicole Collier, a leading voice on health equity, women’s health, and preventive care. From her work on the Select Committee on Preventable Diseases and Women’s Health to her advocacy for fair access to vaccines, Rep. Collier brings...

In this special Thanksgiving episode, Steven helps our community prepare for the conversations that matter most. Every year, GHLF shares its “Turkey Day Talking Points” to support people living with chronic illness or who are immunocompromised as they navigate discussions about vaccines with family and friends.

This episode breaks down simple, compassionate ways to explain why vaccines are so important, and why p...